NO996514L - Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom - Google Patents

Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom

Info

Publication number
NO996514L
NO996514L NO996514A NO996514A NO996514L NO 996514 L NO996514 L NO 996514L NO 996514 A NO996514 A NO 996514A NO 996514 A NO996514 A NO 996514A NO 996514 L NO996514 L NO 996514L
Authority
NO
Norway
Prior art keywords
diagnosis
lyme disease
prevention
compositions
surface antigens
Prior art date
Application number
NO996514A
Other languages
English (en)
Other versions
NO996514D0 (no
Inventor
Mario T Philipp
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of NO996514D0 publication Critical patent/NO996514D0/no
Publication of NO996514L publication Critical patent/NO996514L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Et nytt isoler Borrelia burgdorferi sensu lato overflateantigen er karakterisert med en relativ molekylmasse på 39,5 kDa. Dette antigenet blir uttrykt in vitro av spirocheter fra en B. burgdorferi sensu lato stamme. Dette antigenet induserer antistoffer som avliver spirocheter fra en B. burgdorferi sensu lato stamme med ADCK in vitro. Nytt Borrelia kassettstrengprotein eller fragmenter derav er også nyttige, det er også P39.5 protein i diagnostisering av Lyme sykdom og i sammensetning for behandling av profylakse derav.
NO996514A 1997-06-30 1999-12-28 Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom NO996514L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5127197P 1997-06-30 1997-06-30
PCT/US1998/013551 WO1999000413A1 (en) 1997-06-30 1998-06-29 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease

Publications (2)

Publication Number Publication Date
NO996514D0 NO996514D0 (no) 1999-12-28
NO996514L true NO996514L (no) 2000-02-14

Family

ID=21970280

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996514A NO996514L (no) 1997-06-30 1999-12-28 Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom

Country Status (17)

Country Link
US (2) US6660274B2 (no)
EP (1) EP1012181B1 (no)
JP (1) JP2002511760A (no)
KR (1) KR20010020567A (no)
CN (1) CN1261896A (no)
AR (1) AR016295A1 (no)
AT (1) ATE337335T1 (no)
AU (1) AU8177298A (no)
CA (1) CA2294701C (no)
CO (1) CO4790101A1 (no)
DE (1) DE69835682T2 (no)
DK (1) DK1012181T3 (no)
ES (1) ES2270523T3 (no)
NO (1) NO996514L (no)
PL (1) PL337667A1 (no)
WO (1) WO1999000413A1 (no)
ZA (1) ZA985704B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0894143B2 (en) * 1996-02-21 2012-04-18 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia
WO1999000413A1 (en) * 1997-06-30 1999-01-07 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US6475492B1 (en) * 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
EP1572714A4 (en) 2002-12-20 2006-08-09 Univ Texas SEQUENCES OF SPECIES AND STRAINS OF I BORRELIA / I PATHOGENIC VMP TYPE
WO2007133623A2 (en) * 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
WO2008057396A2 (en) 2006-11-03 2008-05-15 Schering-Plough Ltd. Canine lyme disease vaccine
ES2337113B1 (es) * 2007-04-17 2011-01-24 Centre De Recerca En Sanitat Animal (Cresa) Empleo de la hemaglutinina del virus de la peste porcina africana como adyuvante.
US8247181B2 (en) * 2007-09-07 2012-08-21 The Regents Of The University Of California Borrelia diagnostics and screening methods
WO2010132758A2 (en) * 2009-05-14 2010-11-18 Gomes-Solecki Maria J Ospc-based diagnostic test for lyme disease
WO2011063003A2 (en) 2009-11-17 2011-05-26 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
SI2569008T1 (sl) * 2010-05-14 2020-02-28 Baxalta Incorporated Himere OSPA in njihova uporaba v cepivih
CA2812759A1 (en) 2010-09-27 2012-04-12 Cornell University Methods for diagnosing lyme disease
WO2013067448A2 (en) 2011-11-03 2013-05-10 Vca Antech Inc. Compositions and methods to detect various infectious organisms
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US9670537B2 (en) 2014-06-06 2017-06-06 Titan Collaborative Kithe, Llc Borrelia Provocation Procedure kit
US11061028B2 (en) 2014-09-24 2021-07-13 Defined Diagnostics, Llc Compositions and methods for the diagnosis of lyme disease
JP2018526645A (ja) 2015-08-27 2018-09-13 クイデル コーポレーション ２つ以上の分析物の検出および区別のための２つの流体流路を有する免疫アッセイ試験装置
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
US11446654B2 (en) 2017-02-10 2022-09-20 Quidel Corporation Substrate with channels for controlled fluid flow
CN109596824A (zh) * 2019-01-04 2019-04-09 杭州奥泰生物技术股份有限公司 一种快速诊断莱姆病的检测试纸及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US485551A (en) 1892-11-01 And william
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
EP0339695A3 (en) 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates
ES2092560T5 (es) 1989-12-22 2004-09-16 Mikrogen Molekularbiologische Entwicklungs-Gmbh Proteinas inmunologicamente activas de borrelia burgdorferi, estuches de ensayo relacionados y vacuna.
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
EP0524958B1 (en) 1990-03-05 1996-09-18 THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE Antigenic proteins of borrelia burgdorferi
WO1992000055A1 (en) 1990-06-15 1992-01-09 Yale University Compositions and methods for the prevention and diagnosis of lyme disease
EP1016416A3 (en) 1990-07-06 2002-10-23 Wyeth Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy
EP0894143B2 (en) * 1996-02-21 2012-04-18 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia
DE19632862B4 (de) * 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
WO1999000413A1 (en) * 1997-06-30 1999-01-07 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US6475492B1 (en) * 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease

Also Published As

Publication number Publication date
DE69835682T2 (de) 2007-08-23
KR20010020567A (ko) 2001-03-15
ATE337335T1 (de) 2006-09-15
US20040067517A1 (en) 2004-04-08
EP1012181B1 (en) 2006-08-23
CA2294701C (en) 2009-09-08
US20030059894A1 (en) 2003-03-27
ZA985704B (en) 1999-01-13
WO1999000413A1 (en) 1999-01-07
DK1012181T3 (da) 2007-01-02
PL337667A1 (en) 2000-08-28
EP1012181A1 (en) 2000-06-28
US6660274B2 (en) 2003-12-09
JP2002511760A (ja) 2002-04-16
AR016295A1 (es) 2001-07-04
DE69835682D1 (de) 2006-10-05
CO4790101A1 (es) 1999-05-31
CA2294701A1 (en) 1999-01-07
ES2270523T3 (es) 2007-04-01
NO996514D0 (no) 1999-12-28
CN1261896A (zh) 2000-08-02
AU8177298A (en) 1999-01-19

Similar Documents

Publication Publication Date Title
NO996514L (no) Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom
CY1117387T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
BR9714160A (pt) Antìgenos uspa1 e uspa2 de moraxella catarrhalis
WO2005056600A3 (en) Monoclonal antibodies that bind or neutralize dengue virus
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
BRPI0408085A (pt) composição e método para o tratamento e prevenção de infecções entéricas bacterianas
WO2000077216A3 (en) Porcine circovirus vaccine in recombinant poxvirus
BR9610872A (pt) Proteìna receptora de transferrina de moraxella
ATE430200T1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
ATE453403T1 (de) Wirtszelle enthaltend ein rekombinantes virus, welches ein antigen exprimiert und ein rekombinantes virus, welches ein immunstimulatorisches molekül exprimiert
EP1731166A3 (en) Streptococcus pneumoniae proteins and vaccines
WO2003083485A3 (en) Protein for use in hypoxia related conditions
AU2001276619A1 (en) Immunisation against chlamydia pneumoniae
EP0683234A4 (en) ANTIBODIES DIRECTED AGAINST -g (b) -AMYLOID OR A DERIVATIVE THEREOF AND ITS USE.
EP0090581A3 (en) Small peptides with the specificity of foot and mouth disease viral antigens
DE60036698D1 (de) Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
UA42040C2 (uk) Поліпептид, спосіб діагностики інсулінозалежного цукрового діабету (iddm), що розвинувся або що розвивається (варіанти), набір для діагностики iddm (варіанти), препарат для запобігання або лікування iddm, фармацевтична композиція для профілактики або лікування iddm
NO331277B1 (no) Farmasoytisk sammensetning omfattende polypetid/nukleinsyre for behandling av retinale degenererende sykdommer, vektor, isolert polypeptid, renset antistoff og anvendelse av polypeptid, nukleinsyre og antistoff, samt fremgangsmater og kit
ATE142888T1 (de) Antigen-wirkende proteine von borrelia burgdorferi
DE69737323D1 (de) Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
DE69233311D1 (de) Weidelgraspollen-allergen
AU2002310474A1 (en) Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same
PT868522E (pt) Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application